Literature DB >> 33437836

Can mHealth and eHealth improve management of diabetes and hypertension in a hard-to-reach population? -lessons learned from a process evaluation of digital health to support a peer educator model in Cambodia using the RE-AIM framework.

Lesley Steinman1, Maurits van Pelt2, Heang Hen2, Chhea Chhorvann3, Channe Suy Lan4, Vannarath Te3, James LoGerfo5,6, Annette L Fitzpatrick5,7,8.   

Abstract

BACKGROUND: The burden of non-communicable diseases (NCDs) is increasing in low- and middle-income countries (LMICs) where NCDs cause 4:5 deaths, disproportionately affect poorer populations, and carry a large economic burden. Digital interventions can improve NCD management for these hard-to-reach populations with inadequate health systems and high cell-phone coverage; however, there is limited research on whether digital health is reaching this potential. We conducted a process evaluation to understand challenges and successes from a digital health intervention trial to support Cambodians living with NCDs in a peer educator (PE) program.
METHODS: MoPoTsyo, a Cambodian non-governmental organization (NGO), trains people living with diabetes and/or hypertension as PEs to provide self-management education, support, and healthcare linkages for better care management among underserved populations. We partnered with MoPoTsyo and InSTEDD in 2016-2018 to test tailored and targeted mHealth mobile voice messages and eHealth tablets to facilitate NCD management and clinical-community linkages. This cluster randomized controlled trial (RCT) engaged 3,948 people and 75 PEs across rural and urban areas. Our mixed methods process evaluation was guided by RE-AIM to understand impact and real-world implications of digital health. Data included patient (20) and PE interviews (6), meeting notes, and administrative datasets. We triangulated and analyzed data using thematic analysis, and descriptive and complier average causal effects statistics (CACE).
RESULTS: Reach: intervention participants were more urban (66% vs. 44%), had more PE visits (39 vs. 29), and lower uncontrolled hypertension [12% and 7% vs. 23% and 16% uncontrolled systolic blood pressure (SBP) and diastolic blood pressure (DBP)]. Adoption: patients were sent mean [standard deviation (SD)] 30 [14] and received 14 [8] messages; 40% received no messages due to frequent phone number changes. Effectiveness: CACE found clinically but not statistically significant improvements in blood pressure and sugar for mHealth participants who received at least one message vs. no messages. Implementation: main barriers were limited cellular access and that mHealth/eHealth could not solve structural barriers to NCD control faced by people in poverty. Maintenance: had the intervention been universally effective, it could be paid for from additional revolving drug fund revenue, new agreements with mobile networks, or the government.
CONCLUSIONS: Evidence for digital health to improve NCD outcomes in LMICs are limited. This study suggests digital health alone is insufficient in countries with low resource health systems and that high cell phone coverage did not translate to access. Adding digital health to an NCD peer network may not significantly benefit an already effective program; mHealth may be better for hard-to-reach populations not connected to other supports. As long as mHealth remains an individual-level intervention, it will not address social determinants of health that drive outcomes. Future digital health research and practice to improve NCD management in LMICs requires engaging government, NGOs, and technology providers to work together to address barriers. 2020 mHealth. All rights reserved.

Entities:  

Keywords:  Cambodia; Diabetes; hypertension; implementation science; mHealth

Year:  2020        PMID: 33437836      PMCID: PMC7793020          DOI: 10.21037/mhealth-19-249

Source DB:  PubMed          Journal:  Mhealth        ISSN: 2306-9740


  47 in total

Review 1.  Enhancing the quality and credibility of qualitative analysis.

Authors:  M Q Patton
Journal:  Health Serv Res       Date:  1999-12       Impact factor: 3.402

2.  Chronic disease management: what will it take to improve care for chronic illness?

Authors:  E H Wagner
Journal:  Eff Clin Pract       Date:  1998 Aug-Sep

Review 3.  Changing AIDS-risk behavior.

Authors:  J D Fisher; W A Fisher
Journal:  Psychol Bull       Date:  1992-05       Impact factor: 17.737

Review 4.  How can we increase translation of research into practice? Types of evidence needed.

Authors:  Russell E Glasgow; Karen M Emmons
Journal:  Annu Rev Public Health       Date:  2007       Impact factor: 21.981

5.  The rise of chronic non-communicable diseases in southeast Asia: time for action.

Authors:  Antonio Dans; Nawi Ng; Cherian Varghese; E Shyong Tai; Rebecca Firestone; Ruth Bonita
Journal:  Lancet       Date:  2011-01-25       Impact factor: 79.321

Review 6.  Content analysis and thematic analysis: Implications for conducting a qualitative descriptive study.

Authors:  Mojtaba Vaismoradi; Hannele Turunen; Terese Bondas
Journal:  Nurs Health Sci       Date:  2013-03-11       Impact factor: 1.857

7.  Impact of Text Message Reminders on Caregivers' Adherence to a Home Fortification Program Against Child Anemia in Rural Western China: A Cluster-Randomized Controlled Trial.

Authors:  Huan Zhou; Shuai Sun; Renfu Luo; Sean Sylvia; Ai Yue; Yaojiang Shi; Linxiu Zhang; Alexis Medina; Scott Rozelle
Journal:  Am J Public Health       Date:  2016-04-14       Impact factor: 9.308

8.  Noncommunicable Disease Risk Factors and Mobile Phones: A Proposed Research Agenda.

Authors:  Adnan A Hyder; Adaeze C Wosu; Dustin G Gibson; Alain B Labrique; Joseph Ali; George W Pariyo
Journal:  J Med Internet Res       Date:  2017-05-05       Impact factor: 5.428

9.  Development of a Maternal, Newborn and Child mHealth Intervention in Thai Nguyen Province, Vietnam: Protocol for the mMom Project.

Authors:  Bronwyn McBride; Liem Thanh Nguyen; David Wiljer; Nguyen C Vu; Cuong K Nguyen; John O'Neil
Journal:  JMIR Res Protoc       Date:  2018-01-11

10.  Non-communicable diseases (NCDs) in developing countries: a symposium report.

Authors:  Sheikh Mohammed Shariful Islam; Tina Dannemann Purnat; Nguyen Thi Anh Phuong; Upendo Mwingira; Karsten Schacht; Günter Fröschl
Journal:  Global Health       Date:  2014-12-11       Impact factor: 4.185

View more
  4 in total

1.  The impact of community-based non-pharmacological interventions on cardiovascular and kidney disease outcomes in remote dwelling Indigenous communities: A scoping review protocol.

Authors:  Ikechi G Okpechi; Vinash Kumar Hariramani; Naima Sultana; Anukul Ghimire; Deenaz Zaidi; Shezel Muneer; Mohammed M Tinwala; Feng Ye; Megan Sebastianski; Abdullah Abdulrahman; Branko Braam; Kailash Jindal; Maryam Khan; Scott Klarenbach; Soroush Shojai; Stephanie Thompson; Aminu K Bello
Journal:  PLoS One       Date:  2022-06-10       Impact factor: 3.752

2.  Effects of a Novel Blood Glucose Forecasting Feature on Glycemic Management and Logging in Adults With Type 2 Diabetes Using One Drop: Retrospective Cohort Study.

Authors:  Steven D Imrisek; Matthew Lee; Dan Goldner; Harpreet Nagra; Lindsey M Lavaysse; Jamillah Hoy-Rosas; Jeff Dachis; Lindsay E Sears
Journal:  JMIR Diabetes       Date:  2022-05-03

3.  Clinical and patient-centered implementation outcomes of mHealth interventions for type 2 diabetes in low-and-middle income countries: a systematic review.

Authors:  Moses Mokaya; Florence Kyallo; Roman Vangoitsenhoven; Christophe Matthys
Journal:  Int J Behav Nutr Phys Act       Date:  2022-01-06       Impact factor: 6.457

4.  World Heart Federation Roadmap for Digital Health in Cardiology.

Authors:  Jasper Tromp; Devraj Jindal; Julie Redfern; Ami Bhatt; Tania Séverin; Amitava Banerjee; Junbo Ge; Dipti Itchhaporia; Tiny Jaarsma; Fernando Lanas; Francisco Lopez-Jimenez; Awad Mohamed; Pablo Perel; Gonzalo Emanuel Perez; Fausto Pinto; Rajesh Vedanthan; Axel Verstrael; Khung Keong Yeo; Kim Zulfiya; Dorairaj Prabhakaran; Carolyn S P Lam; Martin R Cowie
Journal:  Glob Heart       Date:  2022-08-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.